These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 6291337

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Contagious ecthyma virus-vaccination failures.
    Buddle BM, Dellers RW, Schurig GG.
    Am J Vet Res; 1984 Feb; 45(2):263-6. PubMed ID: 6711950
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Evolving of live modified sheep pox viral strains: modification of indigenous viral strains.
    Das SK, Mallick BB.
    Indian J Exp Biol; 1986 May; 24(5):282-6. PubMed ID: 3021620
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Enhanced production of antibody with specific antigen.
    Debnath JC, Mallick BB, Das SK.
    Indian J Exp Biol; 1992 Feb; 30(2):73-6. PubMed ID: 1325943
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Experimental contributions to the recognition of dermatitis pustulosa in sheep. V. Investigations into the development of immunity against the dermatitis pustulosa virus at various places of the body surface].
    Schmidt D.
    Arch Exp Veterinarmed; 1967 Feb; 21(4):937-45. PubMed ID: 4299920
    [No Abstract] [Full Text] [Related]

  • 30. The influence of aluminium hydroxide content, dose volume and the inclusion of saponin on the efficacy of inactivated foot-and-mouth disease vaccines.
    Hyslop NS, Morrow AW.
    Res Vet Sci; 1969 Mar; 10(2):109-20. PubMed ID: 5818030
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Effectiveness of HOA formolvaccine against sheep pox].
    Nefed'ev AI.
    Veterinariia; 1971 Feb; 2():63-4. PubMed ID: 4330806
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Studies on the duration of immunity conferred by a live-modified sheep pox tissue culture virus vaccine.
    Ramyar H, Hessami M.
    Zentralbl Veterinarmed B; 1970 Sep; 17(8):869-74. PubMed ID: 4326277
    [No Abstract] [Full Text] [Related]

  • 35. Development of a non-immunising, paraspecific vaccine from attenuated pox viruses: a new type of vaccine.
    Mayr A.
    New Microbiol; 2003 Jan; 26(1):7-12. PubMed ID: 12578306
    [Abstract] [Full Text] [Related]

  • 36. Factors associated with the production of attenuated sheep pox vaccines.
    Chifney ST, Martin WB, Ergin H, Köylü A.
    Res Vet Sci; 1973 Jan; 14(1):62-8. PubMed ID: 4350594
    [No Abstract] [Full Text] [Related]

  • 37. A single vaccine for the control of capripox infection in sheep and goats.
    Kitching RP, Hammond JM, Taylor WP.
    Res Vet Sci; 1987 Jan; 42(1):53-60. PubMed ID: 3029848
    [Abstract] [Full Text] [Related]

  • 38. The alterations in pathogenicity and immunogenicity of a Kenya sheep and goat pox virus on serial passage in bovine foetal muscle cell cultures.
    Davies FG, Mbugwa G.
    J Comp Pathol; 1985 Oct; 95(4):565-72. PubMed ID: 2999199
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.